Related Experiment Video
Updated: Apr 16, 2026

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research
Published on: September 16, 2019
New monoclonal antibodies specific for 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole
Hiroshi Nakayama1, Noriko Kenjyou
1Bioscience Technology Development Office, R&D Division, Panasonic Co. , Souraku-gun, Japan .
Abstract:
1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole (AM694) is one of the synthetic cannabinoids and an illegal drug in Japan. It is important to generate a monoclonal antibody (MAb) against AM694 for use in the rapid and sensitive detection of the drug. Two monoclonal antibodies, named HN0124 (IgG1) and NK0504 (IgG1), were obtained, which were possibly effective for detecting AM694 and its derivatives. The cross-reactive ability of these MAbs was evaluated using a competitive enzyme-linked immunosorbent assay. In the results, both of these antibodies recognize 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole, 1-(5-fluoropentyl)-3-(3-iodobenzoyl)indole, 1-(5-fluoropentyl)-3-(4-iodobenzoyl)indole. Forty nmol/L AM694 can be detected using HN0124 MAb. Thus, MAbs produced in this study could be considered a useful tool for the detection of AM694.
Related Concept Videos
Immunofluorescence Microscopy
Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation,...

